To implement and evaluate flexible models of palliative care service delivery for terminally ill people living alone at home. Provision of evaluated services for this growing population group will lead to better planning and implementation of care being delivered at home, improved quality of life, increased capacity to die at home, and a reduction in hospitalisations and other health care costs.
Imaging Mass Spectrometry (IMS), a peptide biomarker discovery tool using tissue. Cancer is the second most common cause of death in Australia. The newly developed technology of Imaging Mass Spectrometry for peptides in tissue has the potential to discover biomarkers for early diagnosis of cancer. This new technology could avoid a number of cancer deaths and reduce suffering of patients through earlier and better diagnosis.